Laurence Daulhac Selected Research

Laurence Daulhac Research Topics

Disease

12	Pain (Aches) 12/2023 - 10/2006
7	Neuralgia (Stump Neuralgia) 01/2021 - 02/2011
6	Hyperalgesia 01/2021 - 10/2006
3	Hypersensitivity (Allergy) 01/2019 - 10/2006
2	Inflammation (Inflammations) 12/2023 - 01/2019
2	Neoplasms (Cancer) 01/2016 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 06/2010
1	Chronic Pain 12/2019
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Cognitive Dysfunction 01/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Cold Hypersensitivity 01/2013
1	Acute Pain 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2011
1	Painful Neuropathy 02/2011
1	Hypoxia (Hypoxemia) 06/2010
1	Colonic Neoplasms (Colon Cancer) 06/2010
1	Diabetic Neuropathies (Diabetic Neuropathy) 10/2006

Drug/Important Bio-Agent (IBA)

5	Analgesics (Analgesic Drugs)IBA 12/2023 - 09/2008
4	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 02/2007
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2014 - 10/2006
3	Memantine (Namenda)FDA Link 01/2016 - 12/2013
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2015 - 01/2013
2	N-Methylaspartate (NMDA)IBA 12/2013 - 10/2006
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 06/2010
2	Messenger RNA (mRNA)IBA 10/2011 - 06/2010
2	GastrinsIBA 10/2011 - 06/2010
2	Protein Kinases (Protein Kinase)IBA 02/2011 - 10/2006
2	Phosphotransferases (Kinase)IBA 02/2011 - 10/2006
2	Streptozocin (Streptozotocin)FDA Link 02/2011 - 10/2006
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2011 - 10/2006
2	Dizocilpine Maleate (Dizocilpine)IBA 02/2011 - 10/2006
2	U 0126 (UO 126)IBA 02/2011 - 10/2006
1	Opioid Analgesics (Opioids)IBA 12/2023
1	Estrogen ReceptorsIBA 12/2023
1	GTP-Binding Proteins (G-Protein)IBA 12/2023
1	4- chloro- 2- fluoro- N- (2- fluorophenyl)- 5- (hexahydropyrrolo(1,2- a)pyrazin- 2(1H)- ylcarbonyl)benzenesulfonamideIBA 01/2023
1	Pregabalin (Lyrica)FDA Link 01/2021
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 12/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2019
1	Ethosuximide (Zarontin)FDA LinkGeneric 12/2019
1	Calcium Channels (Calcium Channel)IBA 01/2019
1	OxotremorineIBA 12/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2015
1	Cholinergic Agents (Cholinergics)IBA 12/2015
1	Muscarinic M2 ReceptorIBA 12/2015
1	Donepezil (Aricept)FDA LinkGeneric 12/2015
1	CarrageenanIBA 04/2015
1	Ketamine FDA LinkGeneric 12/2014
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 12/2014
1	hexamethylene bisacetamide (HMBA)IBA 01/2013
1	PolyaminesIBA 01/2013
1	ifenprodilIBA 01/2013
1	Glutamic Acid (Glutamate)FDA Link 01/2013
1	4-aminophenolIBA 01/2013
1	Fibronectins (Fibronectin)IBA 10/2011
1	IntegrinsIBA 10/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2011
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010
1	AM 251 (AM251)IBA 09/2008
1	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 09/2008
1	EndocannabinoidsIBA 09/2008
1	maleic acid (maleate)IBA 10/2006
1	JNK Mitogen-Activated Protein KinasesIBA 10/2006
1	SB 203580IBA 10/2006
1	IminesIBA 10/2006
1	pyrazolanthroneIBA 10/2006
1	Mitogen-Activated Protein KinasesIBA 10/2006

Therapy/Procedure

4	Therapeutics 01/2016 - 10/2006
2	Drug Therapy (Chemotherapy) 12/2019 - 01/2016
2	Analgesia 01/2016 - 09/2008
1	Mastectomy (Mammectomy) 01/2016
1	Aftercare (After-Treatment) 01/2016